Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Uwe Wagner

Showing results (131-140 of 209) with videos related to

Pageof 21
Sort By:
Clinical and Translational Medicine|November 29, 2021
The multicellular signalling network of ovarian cancer metastasesLeah Sommerfeld, Florian Finkernagel, Julia M Jansen, et al.
Oncotarget|May 19, 2015
Cyr61 as mediator of Src signaling in triple negative breast cancer cellsMaría Pilar Sánchez-Bailón, Annarica Calcabrini, Víctor Mayoral-Varo, et al.
Blood|December 25, 2012
Differential effects of hydroxyurea and INC424 on mutant allele burden and myeloproliferative phenotype in a JAK2-V617F polycythemia vera mouse modelLucia Kubovcakova, Pontus Lundberg, Jean Grisouard, et al.
International Journal of Cancer|June 21, 2013
Mixed-polarization phenotype of ascites-associated macrophages in human ovarian carcinoma: correlation of CD163 expression, cytokine levels and early relapseSilke Reinartz, Tim Schumann, Florian Finkernagel, et al.
Cellular Signalling|May 10, 2012
Src kinases catalytic activity regulates proliferation, migration and invasiveness of MDA-MB-231 breast cancer cellsMaría Pilar Sánchez-Bailón, Annarica Calcabrini, Daniel Gómez-Domínguez, et al.
Oncotarget|December 22, 2011
Putting the brakes on mammary tumorigenesis: loss of STAT1 predisposes to intraepithelial neoplasiasChristine Schneckenleithner, Zsuzsanna Bago-Horvath, Helmut Dolznig, et al.
Gynecologic Oncology|December 13, 2006
Gefitinib in combination with tamoxifen in patients with ovarian cancer refractory or resistant to platinum-taxane based therapy--a phase II trial of the AGO Ovarian Cancer Study Group (AGO-OVAR 2.6)Uwe Wagner, Andreas du Bois, Jacobus Pfisterer, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 30, 2004
Early onset of neoplasia in the prostate and skin of mice with tissue-specific deletion of PtenStéphanie A Backman, Danny Ghazarian, Kelvin So, et al.
Cancers|December 23, 2022
Prostacyclin Released by Cancer-Associated Fibroblasts Promotes Immunosuppressive and Pro-Metastatic Macrophage Polarization in the Ovarian Cancer MicroenvironmentLeah Sommerfeld, Isabel Knuth, Florian Finkernagel, et al.
Frontiers in Immunology|July 13, 2018
Chromatin Binding of <i>c</i>-REL and p65 Is Not Limiting for Macrophage <i>IL12B</i> Transcription During Immediate Suppression by Ovarian Carcinoma AscitesAnnika Unger, Florian Finkernagel, Nathalie Hoffmann, et al.
Pageof 21

Showing results (131-140 of 209) with videos related to

Sort By:
Pageof 21
Clinical and Translational Medicine|November 29, 2021
The multicellular signalling network of ovarian cancer metastasesLeah Sommerfeld, Florian Finkernagel, Julia M Jansen, et al.
Oncotarget|May 19, 2015
Cyr61 as mediator of Src signaling in triple negative breast cancer cellsMaría Pilar Sánchez-Bailón, Annarica Calcabrini, Víctor Mayoral-Varo, et al.
Blood|December 25, 2012
Differential effects of hydroxyurea and INC424 on mutant allele burden and myeloproliferative phenotype in a JAK2-V617F polycythemia vera mouse modelLucia Kubovcakova, Pontus Lundberg, Jean Grisouard, et al.
International Journal of Cancer|June 21, 2013
Mixed-polarization phenotype of ascites-associated macrophages in human ovarian carcinoma: correlation of CD163 expression, cytokine levels and early relapseSilke Reinartz, Tim Schumann, Florian Finkernagel, et al.
Cellular Signalling|May 10, 2012
Src kinases catalytic activity regulates proliferation, migration and invasiveness of MDA-MB-231 breast cancer cellsMaría Pilar Sánchez-Bailón, Annarica Calcabrini, Daniel Gómez-Domínguez, et al.
Oncotarget|December 22, 2011
Putting the brakes on mammary tumorigenesis: loss of STAT1 predisposes to intraepithelial neoplasiasChristine Schneckenleithner, Zsuzsanna Bago-Horvath, Helmut Dolznig, et al.
Gynecologic Oncology|December 13, 2006
Gefitinib in combination with tamoxifen in patients with ovarian cancer refractory or resistant to platinum-taxane based therapy--a phase II trial of the AGO Ovarian Cancer Study Group (AGO-OVAR 2.6)Uwe Wagner, Andreas du Bois, Jacobus Pfisterer, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 30, 2004
Early onset of neoplasia in the prostate and skin of mice with tissue-specific deletion of PtenStéphanie A Backman, Danny Ghazarian, Kelvin So, et al.
Cancers|December 23, 2022
Prostacyclin Released by Cancer-Associated Fibroblasts Promotes Immunosuppressive and Pro-Metastatic Macrophage Polarization in the Ovarian Cancer MicroenvironmentLeah Sommerfeld, Isabel Knuth, Florian Finkernagel, et al.
Frontiers in Immunology|July 13, 2018
Chromatin Binding of <i>c</i>-REL and p65 Is Not Limiting for Macrophage <i>IL12B</i> Transcription During Immediate Suppression by Ovarian Carcinoma AscitesAnnika Unger, Florian Finkernagel, Nathalie Hoffmann, et al.
Pageof 21